CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Lansing, MI
Sparrow Health - Herbert-Herman Cancer Center 1140 E Michigan Ave, Lansing, MI, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.